Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 32 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				NCCTG-784651


2.		Phase II-III Study with 5-FU/ICRF-159/MeCCNU, 5-FU/ADR with or without MITO or MeCCNU, and 5-FU/MeCCNU for Unresectable Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								GITSG-8376 MAYO-764101

Last Modified: 5/15/2007


3.		Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				14 to 75				NCI				EST-3377


4.		Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MAYO-764802


5.		Phase III 5-FU vs 5-FU/HU vs 5-FU/HU/MeCCNU/DTIC vs MeCCNU/DTIC vs MeCCNU/ICRF vs MITO/DTIC for Advanced Colon and Rectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				EST-1278


6.		Phase I-II Combination Chemotherapy with MITO plus ICRF in Previously Treated Patients with Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								NCI-D78-048-090 WCCC-CO-7722


7.		Phase I-II Chemotherapy with ICRF-159/Adriamycin for Advanced Metastatic Adenocarcinoma of the Gastrointestinal Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								SEG-78GI0102 SEG-78GI238


8.		Phase II Chemotherapy with ICRF-159 for Nonlymphomatous Sarcomas and Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								WLT-26


9.		Phase I Study of Combination Therapy with Adriamycin plus ICRF-159 for Nonlymphomatous Solid Malignant Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								WLT-29


10.		Phase I/II Optimal Dose Level Pilot Study of 5-FU, ICRF-159, MeCCNU plus Triazinate in Various Two-Drug Combinations for Large Bowel Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								MAYO-770304

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute